囊性纤维化病的系统血清学:抗伪蒙马斯IgG1反应和肺功能降低
Shiping Lu1, Kong Chen2, Kejing Song3
1Department of Immunology and Microbiology, Tulane University, New Orleans, LA, USA; Center for Translational Research in Infection and Inflammation, School of Medicine, Tulane University, New Orleans, LA, USA.
Cell reports. Medicine
|October 18, 2023
概括
适应性免疫影响囊性纤维化 (CF) 肺功能. 对Pseudomonas aeruginosa (PA) 抗原的特异性抗体反应,如OprI,在CF患者中加剧肺炎和疾病严重程度.
科学领域:
- 免疫学 免疫学 免疫学
- 肺部病理学 肺部病理学
- 微生物学 微生物学
背景情况:
- 患有F508del突变的囊性纤维化 (CF) 患者表现出不同的肺功能.
- 适应性免疫和对 Pseudomonas aeruginosa (PA) 的抗体反应在CF肺功能中的作用尚未完全理解.
研究的目的:
- 研究适应性免疫,特别是对PA抗原的抗体反应与CF患者的肺功能之间的关联.
- 探索这些抗体反应影响肺炎的机制.
主要方法:
- 在CF患者中对PA外膜蛋白I (OprI) 的血清抗体标位 (免疫球蛋白G1 - IgG1) 的分析,肺功能不同.
- 临床前小鼠模型 (包括Rag2-/-小鼠) 来评估抗OprI抗体对肺炎的影响.
- 转移血清以评估抗体介导的炎症.
- 在接受elexacaftor-tezacaftor-ivacaftor治疗的CF患者中,抗OprIIIgG1标位与肺功能和住院率的相关性分析.
主要成果:
- 肺功能减弱的CF患者表现出较高的抗OprIIIgG1标位和增加的抗体介导补充沉积.
- 在小鼠模型中,具有补充活性的抗OprI抗体加剧了肺炎.
- 这种炎症在Rag2-/-小鼠中不存在,可以通过血清转移.
- 降低抗OprIIIgG1标位与改善的肺功能和CFTR调节器治疗CF患者的住院减少相关.
结论:
- 对特定Pseudomonas aeruginosa抗原的抗体反应,特别是OprI,有助于肺炎,并在囊性纤维化中恶化肺功能.
- 准这些自适应性免疫反应可能为治疗CF肺部疾病提供治疗策略.
更多相关视频
07:46Use of Artificial Sputum Medium to Test Antibiotic Efficacy Against Pseudomonas aeruginosa in Conditions More Relevant to the Cystic Fibrosis Lung
Published on: June 5, 2012
33.1K
03:53Growing a Cystic Fibrosis-Relevant Polymicrobial Biofilm to Probe Community Phenotypes
Published on: April 19, 2024
566
相关概念视频
01:23Cystic Fibrosis: Pathogenesis
256
Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
256
01:24Cystic Fibrosis: Management
173
Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
Sinus disease and chronic...
173
01:30Pneumonia III: Complications and Assessment
242
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
242